Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: A randomized placebo-controlled study;Artigo Recomendado do Měs

Revista Portuguesa de Cardiologia

Volumn 20, Issue 11, 2001, Pages 1151-1152

  Channick, R N ^a   Simonneau, G ^a   Sitbon, O ^a   Robbins, I M ^a   Frost, A ^a   Tapson, V F ^a   Badesch, D B ^a   Roux, S ^a   Rainisio, M ^a   Bodin, F ^a   Rubin, L J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BERAPROST; BOSENTAN; ENDOTHELIN RECEPTOR ANTAGONIST; ILOPROST; PLACEBO; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; TREPOSTINIL; UNCLASSIFIED DRUG; ANTIHYPERTENSIVE AGENT; SULFONAMIDE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESEARCH; HUMAN; MEDICAL LITERATURE; NOTE; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ARTICLE;

ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION, PULMONARY; RANDOMIZED CONTROLLED TRIALS; SULFONAMIDES;

EID: 0035525137     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (13)

1. Primary Pulmonary Hypertension: Natural history and the importance of thrombosis
2. The effect of high doses of calcium-channel blockers on survival in Primary Pulmonary Hypertension
3. Treatment of primary pulmonary hypertension with continuos intravenous prostacyclin (epoprostenol). Results of a randomized trial
4. A comparison of continnos intravenons epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
5. Reduction in pulmonary vascular resistance with long-term epoprostenol (Prostacyclin) therapy in Primary Pulmonary Hypertension
6. Treatment with epoprostenol reverts nitric oxide non-responsiveness in patients with primary pulmonary hypertension
7. Long-term treatment of Primary Pulmonary Hypertension with aerosolized Hoprost, a Prostacyclin analogue
8. Effect of orally active Prostacyclin analogue on survival of outpatients with Primary Pulmonary Hypertension
9. Comparative relation of neurohormonal activation to hemodynamics in primary or precapillary secondary pulmonary hypertension
10. Relation of endothelin-1 to survival in patients with primary pulmonary hypertension
11. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: An ambulatory delivery system and initial clinical tests
12. Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension